Active Substance: Vaccine - Hepatitis A vaccine (inactivated virus).
Overview
Welcome to Dwaey, specifically on HAVRIX 720 Junior Monodose VACCINE page.
This medicine contains an important and useful components, as it consists of
Vaccine - Hepatitis A vaccine (inactivated virus)is available in the market in concentration
Hepatits A Vaccine (HAV Antigen)
Alcohol or disinfectant used for cleaning the skin prior to inj should be allowed to evaporate completely before vaccination to prevent vaccine inactivation. Lactation: not established
Active immunisation against Hepatitis A virus
Hypersensitivity. Vaccines prepared in egg cultures are contraindicated in patients with hypersensitivity reactions to egg. Severe immunodeficiency. Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 mth after stopping treatment. Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressants or HIV positive.
>10% Injection site tenderness (3-56%), erythema (1-22%), warmth (1-17%), swelling (9-11%),Irritability (11-36%),Anorexia (1-19%),Drowsiness (15-17%),Headache (1-16%),Fever > 100.4 F (9-11%) 1-10% URI (1-10%),Otitis media (8%),Rhinorrhea (6%),Diarrhea (1-6%),Cough (1-5%),Rash (1-5%),Weakness/fatigue (4%),Vomiting (1-4%),Fever > 102 F (3%),Crying (2%) <1% Hematoma,Incr. CPK,Photophobia,Vertigo Potentially Fatal: Anaphylaxis.
3
Hepatitis A antigen is prepared from formaldehyde-inactivated hepatitis A virus grown in human diploid cells. It is used for active immunisation against hepatitis A infection.
Reduced response to vaccination when used concurrently with immunosuppressants such as corticosteroids or antineoplastics.
Information not available